Adjuvant chemotherapy after surgery for invasive Intraductal papillary mucinous neoplasms of the pancreas: the potential survival benefit depends on the specific subtype

Objectives Little is known about the role of adjuvant treatment after surgery for malignant Intraductal Papillary Mucinous Neoplasms (IPMNs). The aim of this study is to assess the potential role of adjuvant chemotherapy in terms of improvement of survival.

Source: Pancreatology - June 1, 2018 Category: Gastroenterology Authors: Giovanni Marchegiani, Chiara Dal Borgo, Stefano Andrianello, Erica Secchettin, Davide Melisi, Giuseppe Malleo, Claudio Bassi, Roberto Salvia Tags: 8. Pancreatic Cancer I Source Type: research